Impact of genotype and morphology on the prognosis of glioblastoma

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 4, 2002, Pages 321-328

  Schmidt, Matthias C ^a   Antweiler, Sven ^a   Urban, Nina ^a   Mueller, Wolf ^a   Kuklik, A ^a   Meyer Puttlitz, Birgit ^a   Wiestler, Otmar D ^a   Louis, David N ^a   Fimmers, Rolf ^a   Von Deimling, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allelic losses; Glioblastoma; Molecular diagnostics; Prognosis

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; ARTICLE; CANCER SURVIVAL; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 19Q; CHROMOSOME 1P; CLINICAL FEATURE; GENETIC ANALYSIS; GENOTYPE; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MORPHOLOGY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS;

EID: 0036201832     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.4.321     Document Type: Article

References (36)

1. Histologic factors of prognostic significance in the glioblastoma multiforme
2. Glioblastoma multiforme and anaplastic astrocytoma, pathologic criteria and prognostic implications
3. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
4. Molecular genetic analysis of giant cell glioblastomas
5. p53 mutations versus EGF receptor expression in giant cell glioblastomas
6. Subsets of glioblastoma multiforme defined by molecular genetic analysis
7. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
8. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme
9. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
10. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
11. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis
12. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
13. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE
14. A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens
15. PTEN mutations in gliomas and glioneuronal tumors
16. A rapid and non radioactive PCR based assay for the detection of allelic loss in human gliomas
17. A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors
18. Cerebral astrocytomas and their derivatives
19. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
20. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression
21. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes
22. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients
23. Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: Results of a meta-analysis
24. Allele loss on chromosome 10 and 17p and epidermal growth factor receptor amplification in human malignant astrocytoma related to prognosis
25. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
26. Differential expression of MMAC/ PTEN in glioblastoma multiforme: Relationship to localization and prognosis
27. Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations
28. Loss of heterozygosity studies in human gliomas
29. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas and mixed gliomas
30. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
31. Molecular analysis of chromosome 1 abnormalities in human gliomas reveals frequent loss of 1p in oligodendroglial tumors
32. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma
33. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome lp loss
34. Molecular genetic alterations in glioblastomas with oligodendroglial component
35. Loss of heterozygosity on chromosome 19 in secondary glioblastomas